Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDC like kinase 3 pseudogene 2 (CLK3P2) is a genomic sequence homologous to the protein kinase gene CDC like kinase 3 (CLK3), but it is classified as a pseudogene and does not produce a functional protein[4]. Pseudogenes may arise from gene duplication or retrotransposition and typically lack biological activity in cellular signaling, splicing, or other molecular functions. No data support CLK3P2 as a receptor, enzyme, transporter, transcription factor, drug target, or disease marker. The functional protein target in this family is CDC like kinase 3 (CLK3), a nuclear dual-specificity kinase involved in RNA splicing regulation and oncogenic processes such as metabolic reprogramming and alternative splicing[1][3][5][8]. The pseudogene itself is not associated with disease roles, drugs, mechanisms of action, biomarkers, or safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDC like kinase 3 pseudogene 2 (CLK3P2).